ALFA Finder
The call ran from 2:59 PM to 3:34 PM IST (35 min).
Key takeaways
Consolidated Q2 revenue ₹7,615 Cr (+23%), EBITDA ₹1,191 Cr (+29%), margin 15.6% vs 14.9%. Growth is solid, but Apollo Health Co's FY27 margin outlook was trimmed and management avoided explicit hospital growth guidance.
| Revenue growth | Consolidated +23% YoY; healthcare services +23%, Health Co +23%, AHLL +20%. |
|---|---|
| Margins | EBITDA margin 15.6% vs 14.9%; established hospitals 25.8%, up 61bps. |
| Demand visibility | Inpatient volumes +14%, occupancy 73%; structural demand cited as strong. |
| Management confidence | Optimistic tone; declined explicit 20% hospital growth guidance, deflected. |
Growth
Revenue +23%, EBITDA +29%, PAT +32%. Established hospitals grew 19%, while new hospitals added ₹135 Cr revenue with a ₹35 Cr EBITDA loss.
Outlook
Guides ₹1,500 Cr+ integrated EBITDA for FY27. 1,395 beds: 520 commissioned, remainder in 12-18 months. Demerger targeted for Q4 FY27.
Risks
Apollo Health Co margin outlook weaker; one-time integration costs in H2. MRP revision from 9 Nov may pressure pharmacy margins; insurance remains loss-making.
Last quarter's promises, checked
Partly delivered
- Guided 620 of 1,000 census beds live in 12-18 mo (380 live in Q1) → 520 of 1,395 beds commissioned, +140 in Q2; base changed (= PARTIAL)
- Guided Jubilee Hills brownfield expansion for FY28-29 → 'underway' per current call, no capacity figure (= PARTIAL)
Summary by ALFA Finder, written with AI assistance from the earnings call transcript the company filed, published . Open it on ALFA Filings ›
The results behind this call
Apollo Hospitals Enterprise Q2 FY27 Results: Net Profit ₹659.5 Cr, Up 33.5% YoY
Apollo Hospitals Enterprise Ltd reported revenue from operations of ₹7,615 Cr (+23.0% YoY) and net profit of ₹659.5 Cr (+33.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹659.5 Cr · +33.5% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
Targeting 20% revenue growth in hospitals and census capacity expansion to 14,100 beds by FY31.
Growth they described
Strong volume-led growth (11%) and case complexity shift drove ARPOB up 8% to ₹1,86,632.
Call details
| Company | Apollo Hospitals Enterprise Limited |
|---|---|
| NSE symbol | APOLLOHOSP |
| ISIN | INE437A01024 |
| Call | Q2 FY27 earnings call |
| Date | Thursday, 5 November 2026 |
| Time | 3:00 PM IST |
| Length | 35 min |
Apollo Hospitals Enterprise Limited: key numbers
- Share price
- ₹8,502.00
- Market cap
- ₹1,22,246 Cr
- Revenue (annual)
- ₹25,228 Cr
- Net profit (annual)
- ₹1,942 Cr
- P/E (TTM)
- 54.5×Sector 54.5×
- Promoter holding
- 28.02%+0.00% QoQ
- FII holding
- 43.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Other calls on Thu, 5 Nov
Today's concalls →
